AXCELIS ANNOUNCES FOLLOW ON SHIPMENTS OF PURION POWER SERIES IMPLANTERS TO POWER DEVICE CHIPMAKER IN JAPAN
On March 31, 2022, Axcelis Technologies (Nasdaq: ACLS) announced follow-on shipments of its Purion XE™ and Purion M™ implanters to a major power device chipmaker in Japan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
On March 31, 2022, Axcelis Technologies (Nasdaq: ACLS) announced follow-on shipments of its Purion XE™ and Purion M™ implanters to a major power device chipmaker in Japan. These systems are meant for the high-volume production of 300mm thin silicon wafer-based MOSFET and IGBT devices used in automotive and power management applications. Executive VP Bill Bintz stated that the Purion Power Series' unique capabilities position Axcelis for growth in this market and they aim to enhance their footprint in Japan.
Positive
- Follow-on shipments of Purion XE™ and Purion M™ implanters signal strong demand in the semiconductor sector.
- Positioning in the rapidly expanding power device market could enhance revenue streams.
Negative
- None.
Details
News Market Reaction – ACLS
The recorded move for ACLS in the trading session of this news was -2.48%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Purion Power Series Features 300mm Thin Wafer Handling Capability
View original content to download multimedia:https://www.prnewswire.com/news-releases/axcelis-announces-follow-on-shipments-of-purion-power-series-implanters-to-power-device-chipmaker-in-japan-301514501.html
SOURCE Axcelis Technologies, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.